Stability Study of Baclofen in an Oral Powder Form Compounded for Pediatric Patients in Japan

Stability Study of Baclofen in an Oral Powder Form Compounded for Pediatric Patients in Japan

Baclofen is used as a skeletal muscle relaxant for multiple sclerosis patients and pediatric patients with cerebral palsy and is prescribed to pediatric patients at 0.3 to 1.0 mg/kg/dose. Baclofen tablets, an oral drug, are usually administered as a powder in pediatric wards after a formulation chan...

Full description

Bibliographic Details
Main Authors: Jumpei Saito, Takehisa Hanawa, Ayuna Ozawa, Takahiro Matsumoto, Nozomi Yoshikawa, Tsutomu Harada, Kana Iwahashi, Akimasa Yamatani
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Children
Subjects:
baclofen
pediatric formulation
oral powder
stability
quality assurance
Online Access:https://www.mdpi.com/2227-9067/9/9/1313

Internet

https://www.mdpi.com/2227-9067/9/9/1313

Similar Items